Literature DB >> 2992661

Different responsiveness of prostaglandin D2-sensitive systems to prostaglandin D2 and its analogues.

S Narumiya, N Toda.   

Abstract

Prostaglandin D2 (PGD2) and six PGD2 analogues were used to classify responsiveness of several PGD2-sensitive systems. The analogues used were 9 beta-PGD2, 5-(6-carboxyhexyl)-1-(3-cyclohexyl-3-hydroxypropyl)hydantoin (BW245C), 17-phenyl-18,19,20-trinor-PGD2 (17-phenyl-PGD2), PGD2 amide, PGD2 N-monomethylamide and 11-keto-15 alpha-hydroxy-delta 5,9,12-prostenoic acid (9-deoxy-delta 9,12-PGD2). The PGD2-sensitive systems examined were human platelets, rat peritoneal mast cells, rabbit transverse stomach strip, guinea-pig tracheal ring chain and helical strip of the dog cerebral artery. PGD2, 9 beta-PGD2 and BW245C inhibited the aggregation of human platelets, increased adenosine 3'5'-cyclic monophosphate (cyclic AMP) in rat mast cells and relaxed the rabbit stomach strip. The rank order of potency was BW245C greater than PGD2 greater than 9 beta-PGD2. PGD2 amide and PGD2 N-monomethylamide were inactive in the former two systems but elicited relaxant activity on the rabbit stomach strip. 17-Phenyl-PGD2 was virtually inactive in the above three systems. PGD2 and 17-phenyl-PGD2 contracted the guinea-pig tracheal ring chain and the helical strip of dog cerebral arteries with almost equal potency. 9 beta-PGD2 and BW245C antagonized competitively the contractile action of PGD2. PGD2 amide and PGD2 N-monomethylamide showed weak agonistic actions in the tracheal preparation. 9-Deoxy-delta 9,12-PGD2, showing stronger growth inhibition than PGD2 on cultured tumour cells, was inactive in human platelets, rat mast cells and guinea-pig trachea, and elicited contractile response in the rabbit stomach strip. These results indicate the presence of three groups of PGD2-sensitive systems that respond differently to PGD2 and its analogues.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2992661      PMCID: PMC1916609          DOI: 10.1111/j.1476-5381.1985.tb08870.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  Prostaglandin endoperoxides IV. Effects on smooth muscle.

Authors:  M Hamberg; P Hedqvist; K Strandberg; J Svensson; B Samuelsson
Journal:  Life Sci       Date:  1975-02-01       Impact factor: 5.037

2.  Aggregation of blood platelets by adenosine diphosphate and its reversal.

Authors:  G V BORN
Journal:  Nature       Date:  1962-06-09       Impact factor: 49.962

3.  Identification of platelet receptors for prostaglandin I2 and D2.

Authors:  A I Schafer; B Cooper; D O'Hara; R I Handin
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

4.  An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue.

Authors:  M Honma; T Satoh; J Takezawa; M Ui
Journal:  Biochem Med       Date:  1977-12

5.  Stimulation of human platelet adenylate cyclase by prostaglandin D2.

Authors:  D C Mills; D E Macfarlane
Journal:  Thromb Res       Date:  1974-09       Impact factor: 3.944

6.  Inflammatory effects of prostaglandin D2 in rat and human skin.

Authors:  R J Flower; E A Harvey; W P Kingston
Journal:  Br J Pharmacol       Date:  1976-02       Impact factor: 8.739

7.  Definition of prostaglandin-sensitive arterial constrictor systems.

Authors:  R L Jones
Journal:  Acta Biol Med Ger       Date:  1978

8.  Use of the rabbit transverse stomach-strip to identify and assay prostacyclin, PGA2, PGD2 and other prostaglandins.

Authors:  B J Whittle; K G Mugridge; S Moncada
Journal:  Eur J Pharmacol       Date:  1979-01-01       Impact factor: 4.432

9.  Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.

Authors:  B J Whittle; S Moncada; J R Vane
Journal:  Prostaglandins       Date:  1978-09

10.  Plaque formation and isolation of pure lines with poliomyelitis viruses.

Authors:  R DULBECCO; M VOGT
Journal:  J Exp Med       Date:  1954-02       Impact factor: 14.307

View more
  26 in total

1.  Prostaglandin D2 DP1 receptor is beneficial in ischemic stroke and in acute exicitotoxicity in young and old mice.

Authors:  Abdullah Shafique Ahmad; Muzamil Ahmad; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  Age (Dordr)       Date:  2010-03-05

2.  Analyzing isolated blood vessel contraction in multi-well plates.

Authors:  Ricardo Borges; David Díaz-Martín; José G Hernández-Jiménez; Manuel Rodríguez-Valido; Beatriz Beltrán
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-02-23       Impact factor: 3.000

Review 3.  Prostanoid signaling: dual role for prostaglandin E2 in neurotoxicity.

Authors:  Dejan Milatovic; Thomas J Montine; Michael Aschner
Journal:  Neurotoxicology       Date:  2011-03-03       Impact factor: 4.294

4.  Role of the L-PGDS-PGD2-DP1 receptor axis in sleep regulation and neurologic outcomes.

Authors:  Abdullah Shafique Ahmad; Haneen Ottallah; Carolina B Maciel; Michael Strickland; Sylvain Doré
Journal:  Sleep       Date:  2019-06-11       Impact factor: 5.849

5.  AH6809, a prostaglandin DP-receptor blocking drug on human platelets.

Authors:  R J Keery; P Lumley
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

6.  Dual functions of prostaglandin D2 in murine contact hypersensitivity via DP and CRTH2.

Authors:  Yoshihiro Yamamoto; Shinobu Otani; Hiroyuki Hirai; Kinya Nagata; Kosuke Aritake; Yoshihiro Urade; Shuh Narumiya; Hiroo Yokozeki; Masataka Nakamura; Takahiro Satoh
Journal:  Am J Pathol       Date:  2011-05-10       Impact factor: 4.307

7.  Dendritic cells express hematopoietic prostaglandin D synthase and function as a source of prostaglandin D2 in the skin.

Authors:  Chieko Shimura; Takahiro Satoh; Ken Igawa; Kosuke Aritake; Yoshihiro Urade; Masataka Nakamura; Hiroo Yokozeki
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

8.  Indomethacin inhibits eosinophil migration to prostaglandin D2 : therapeutic potential of CRTH2 desensitization for eosinophilic pustular folliculitis.

Authors:  Naoko Kataoka; Takahiro Satoh; Aiko Hirai; Kazumi Saeki; Hiroo Yokozeki
Journal:  Immunology       Date:  2013-09       Impact factor: 7.397

Review 9.  Prostanoid receptor antagonists: development strategies and therapeutic applications.

Authors:  R L Jones; M A Giembycz; D F Woodward
Journal:  Br J Pharmacol       Date:  2009-07-15       Impact factor: 8.739

10.  Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene.

Authors:  M Hirata; A Kakizuka; M Aizawa; F Ushikubi; S Narumiya
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.